| Name | 4-[3-[4-(2-methylimidazol-1-yl)phenyl]sulfanylphenyl]oxane-4-carboxamide |
|---|---|
| Synonyms | Tetrahydro-4-[3-[[4-(2-methyl-1H-imidazol-1-yl)phenyl]thio]phenyl]-2H-pyran-4-carboxamide |
| Description | CJ-13,610, a nonredox-type 5-LO inhibitor, dose dependently suppresses 5-LO product formation in ionophore A23187-stimulated PMNL in the absence of exogenous AA with an IC50 of about 70 nM[1]. PMNL: polymorphonuclear leukocytes; AA: arachidonic acid |
|---|---|
| Related Catalog | |
| References |
| Melting Point | 198 - 200 °C |
|---|---|
| Molecular Formula | C22H23N3O2S |
| Molecular Weight | 393.50200 |
| Exact Mass | 393.15100 |
| PSA | 96.43000 |
| LogP | 5.01510 |
| Storage condition | 2-8°C |
| RIDADR | NONH for all modes of transport |
|---|